Respiratory syncytial virus (RSV) is increasingly recognized as a major pathogen in frail older adults and a cause of exacerbations of chronic obstructive pulmonary disease (COPD). Although there are studies examining the burden in hospitalized COPD cohorts, there has been no work evaluating the burden in the outpatient setting in this group.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Molecular Classification, FIGO 2023, and Chemoimmunotherapy
Endometrial carcinoma
- Psoriatic Arthritis
Older patients at risk for tachyarrhythmias
- Genetic Kidney Disease: DOUBLE PROTECT Alport
The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade
- Case Study: Cystic Fibrosis in Adults
Recurrent Pneumonia as a Manifestation of Cystic Fibrosis
- Long COVID/Fatigue Clinic
An Innovative Approach: Neuroplasticity and Predictive Processing
- T-cell lymphomas
Diagnostic Challenges and New Treatment Options
- Interbrain Synchrony
Two Brains, One Thought
- Atopic Dermatitis in Children and Adults